No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024's 'Biggest Loses' That Could See Reversal in 2025
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects?
Insider Buying: QuidelOrtho President Bought US$250k Of Shares
Worst Performing Stocks for Tax Loss Selling – Wolfe